Project Grant R01AG090465
Award Date
12/1/24
Completion Date
11/30/29
Dollars Obligated
$657K
Federal Agency
National Institute on Aging
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
New Haven, CT 06519, USA
Similar Awards
This federal Project Grant award, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to define the mechanisms that coordinate late endosome and lysosome functions across the size and polarity of neurons. The $605,486 grant, awarded on January 1, 2025, will fund research at Yale University to address the lack of understanding regarding how the network of proteins that control lysosome function is integrated to support the unique demands of neurons. The research...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) is providing $461,313 to Yale University to investigate the role of the protein CSPα in regulating synaptic autophagy and its implications for neurodegenerative diseases. The key objectives are to: Characterize synaptic vesicles, vesicles targeted for autophagy, and synaptic autophagosomes in wild-type and CSPα knockout mouse brains using electron microscopy and quantitative mass spectrometry....
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $146,922 to Rockefeller University to conduct research aimed at understanding the molecular determinants of the mRNA export platform and how aging-associated mutations affect its assembly and impact gene regulation. The key objectives are to: 1) Generate a high-resolution integrative model of the mRNA export platform using techniques like cryo-EM and crosslinking mass spectrometry, and...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $351,750 to Yale University to investigate the role of the protein NLRX1 in age-related changes to the immune system, particularly T cell function. The 5-year project aims to elucidate how decreases in NLRX1 may contribute to the expansion of memory T cells, decreased naive T cell survival, and other age-associated T cell alterations. The research will explore the mechanisms by which NLRX1...
This Project Grant award from the National Institute on Aging's (NIA) Aging Research program (CFDA 93.866) provides $660,402 to the University of Maryland, Baltimore (UMB) to study the role of autophagy, a cellular process that recycles damaged components, in regulating lipid metabolism and inflammation in microglia during brain aging and neurodegenerative diseases like Alzheimer's disease (AD). The research aims to determine how microglial lipid phagocytosis inhibits autophagy, leading to the...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $431,132 to Albert Einstein College of Medicine to conduct research on the loss of the Y chromosome (LOY) and its implications in the aging process. The project aims to achieve an integrated understanding of LOY, including investigating rare genetic variants that influence its manifestation and decoding the relationship between LOY and age-related diseases. The research will utilize...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $793,777 to the J. David Gladstone Institutes to conduct research on the impact of mitochondrial genome architecture on the accumulation of somatic mitochondrial DNA (mtDNA) mutations and their role in cellular aging and age-related degenerative diseases. The study will utilize long-read sequencing approaches to quantify accessibility, mutations, and damage along individual mtDNA...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $227,250 to Saint Louis University to investigate the role of the protease cathepsin L in modulating the nuclear proteome, particularly in relation to lamin proteins involved in cellular aging and disease. The 2-year project, running from November 2024 to October 2026, aims to elucidate the mechanisms by which cathepsin L can mitigate the toxic effects of the progerin protein that causes...
This Project Grant award for $466,125, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), supports research to analyze the effects of Alzheimer's disease on subcellular transcriptome dynamics and mitonuclear coordination in neuronal soma and projections. The research, conducted by Harvard Medical School, will use a novel technique called Subcellular Timelapse-Seq (STL-Seq) to simultaneously quantify the kinetic rates of transcription, nuclear export, ribosome...
This $871,093 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the Sloan-Kettering Institute for Cancer Research supports research to elucidate the mechanisms underlying the regulation of the transcription factor TFEB and the autophagy-lysosomal pathway, and to investigate their therapeutic potential as treatments for Alzheimer's disease. The key objectives are to study how the protein phosphatases CDC25A and PP2A regulate TFEB signaling and the...